| 摘要 |
PCT No. PCT/IT97/00056 Sec. 371 Date Sep. 15, 1998 Sec. 102(e) Date Sep. 15, 1998 PCT Filed Mar. 12, 1997 PCT Pub. No. WO97/34596 PCT Pub. Date Sep. 25, 1997The use of an alkanoyl-L-carnitine, e.g., acetyl-L-carnitine, or a pharmacologically acceptable salt thereof is disclosed to produce a medicament for the therapeutic treatment or prophylaxis of glutamate-mediated cytological disturbances or diseases. |
